An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Author:
Affiliation:
1. The Engineering Research Centre of Peptide Drug Discovery and Development China Pharmaceutical University Nanjing Jiangsu China
2. State Key Laboratory of Natural Medicines Ministry of Education China Pharmaceutical University Nanjing China
Funder
Priority Academic Program Development of Jiangsu Higher Education Institutions
Publisher
Wiley
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3768
Reference42 articles.
1. Integrin-associated protein (CD47) and its ligands
2. In vivo expression of alternatively spliced forms of integrin‐associated protein (CD47);Reinhold MI;J Cell Sci,1995
3. Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47
4. CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
5. CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics;ChemMedChem;2024-09-12
2. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
3. Dual Template Molecularly Imprinted Polymers Targeting Blockade of CD47 for Enhanced Macrophage Phagocytosis and Synergistic Antimetabolic Therapy;ACS Applied Materials & Interfaces;2024-07-30
4. Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy;Journal of Nanobiotechnology;2024-07-20
5. Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma;Annals of Hematology;2024-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3